Italy's antitrust regulator has initiated an investigation into the U.S. pharmaceutical company Biogen. The probe concerns allegations that Biogen holds a dominant position in the market. The specific details or therapeutic areas of the alleged dominance were not immediately specified.

Citigroup has increased its price target for Voyager Technologies, Inc. (VOYG) to $44 from $36, while maintaining a Buy rating. This adjustment follows revised models for the aerospace and defense sectors, with Citigroup noting buying opportunities despite anticipating a slower recovery without an end to the Iran war. Voyager Technologies has seen its shares rise 70% since its Q1 2026 results and is collaborating on an automated drug screening mission in space.

Italy's antitrust authority has launched an investigation into drug maker Biogen Italia and its parent company Biogen for alleged abuse of a dominant position. The probe stems from claims that Biogen sought to exclude its rival Sandoz from the market for multiple sclerosis drugs that use the active ingredient natalizumab. Inspections were carried out at Biogen's Italian offices, with assistance from Italy's finance police.

Advanced Micro Devices (NASDAQ:AMD) has received an average recommendation of "Moderate Buy" from forty-four brokerage firms. Analysts have an average 12-month price target of $410.00 for AMD, with several firms recently increasing their targets due to growing optimism and strong quarterly results where AMD beat EPS and revenue estimates. The article also highlights significant insider stock sales and institutional investor activity, alongside current market performance and various news sentiments surrounding the company.

Regeneron Pharmaceuticals (REGN) stock is presented as a potentially good investment due to its strong cash yield of 5.7%, robust operating margin of 25.8%, and discounted valuation. Despite relatively lower revenue growth, the company's fundamentals appear attractive, trading significantly below its 2-year and 1-month highs. The article suggests that such companies can fuel growth or reward shareholders through dividends or buybacks.

Toyota is recalling over 43,500 model-year 2024 Tundra pickup trucks equipped with the V35A engine due to a potential engine failure. Debris from the manufacturing process can contaminate the engine, leading to main bearing failure, loss of drive power, and an increased risk of a crash. Toyota is currently developing a remedy, and affected owners will be notified by July 6.

Allegion PLC (NYSE:ALLE) has been assigned an average rating of "Hold" by analysts, with a consensus price target of $161.50. The company reported quarterly EPS of $1.80, missing estimates, but revenue matched expectations at $1.03 billion, up 9.7% year-over-year. Allegion's board also approved a $500 million share buyback and declared a quarterly dividend of $0.55 per share.

Johnson & Johnson (NYSE:JNJ) has received an average rating of "Moderate Buy" from analysts, with 20 buy ratings and 7 hold ratings, and an average 12-month price target of $253.04. The company recently reported strong Q1 results, exceeding EPS and revenue expectations, and raised its full-year 2026 EPS guidance while also increasing its quarterly dividend. Despite positive sentiment from product distribution agreements and its dividend strength, J&J faces ongoing risks from talc litigation and potential drug-pricing pressure.

Wells Fargo has reiterated its Buy rating for Palo Alto Networks (PANW) with a price target of $285. This follows Cantor Fitzgerald also raising its price target to $285, anticipating strong third-quarter results driven by platformization and large deal momentum. Palo Alto Networks recently launched Idira, a new identity security platform, expanding its cybersecurity offerings.

AkzoNobel has rejected a $14.53 billion takeover proposal from Nippon Paint Holdings and Sherwin-Williams, asserting that the offer was not superior to its existing merger agreement with Axalta Coating Systems. The Dutch paint maker is proceeding with its previously announced all-stock merger with Axalta to create a global paint giant valued at approximately $17 billion, despite some shareholder opposition.